In vitro cell based cytotoxicity and T cell activation assays to assess safety and efficacy of engineered T cell therapies

被引:0
|
作者
Holt, Sanne [1 ]
Vermond, Sophie [1 ]
Hazenoot, Monique Hazenoot [1 ]
Overman, Jeroen [1 ]
Aarbiou, Jamil Aarbiou [1 ]
DeGroot, Jeroen DeGroot [1 ]
机构
[1] Charles River Labs, Leiden, Netherlands
关键词
D O I
10.1158/1538-7445.AM2020-3232
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3232
引用
收藏
页数:2
相关论文
共 50 条
  • [21] ICARS: ENGINEERED SAFETY FOR T CELL IMMUNOTHERAPY
    Fedorov, V.
    Themeli, M.
    Sadelain, M.
    [J]. HAEMATOLOGICA, 2014, 99 : 796 - 796
  • [22] Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies
    Stone, Jennifer D.
    Kranz, David M.
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [23] Recent Advances in Engineered T Cell Therapies Targeting B Cell Malignancies
    Singh, Nathan
    [J]. DISCOVERY MEDICINE, 2016, 22 (121) : 215 - 220
  • [24] In vitro cytotoxicity assays to support CAR T cell evaluation against solid tumors
    Castro, Carla N.
    Bergo, Veronica
    Weber, Holger
    Metzger, Philipp
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [25] Combined analysis of T cell activation and T cell-mediated cytotoxicity by imaging cytometry
    Chanda, Monica Kasturi
    Shudde, Claire E.
    Piper, Taylor L.
    Zheng, Yating
    Courtney, Adam H.
    [J]. JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [26] Improved T cell activation bioassays for development of bispecific antibodies and engineered T cell immunotherapies
    Stecha, Pete
    Garvin, Denise
    Hartnett, Jim
    Swanson, Brad
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [27] Modeling and Simulation Studies to Assess Safety and Efficacy of CAR T Cell Therapy
    Nukala, Ujwani
    Yogurtcu, Osman
    Yang, Hong
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 505 - 506
  • [28] T cell therapies
    Gottschalk, S.
    Bollard, C. M.
    Straathof, K. C.
    Louis, C. U.
    Savoldo, B.
    Dotti, G.
    Brenner, M. K.
    Heslop, H. E.
    Rooney, C. M.
    [J]. IMMUNOTHERAPY IN 2020: VISIONS AND TRENDS FOR TARGETING INFLAMMATORY DISEASE, 2007, 4 : 69 - +
  • [29] Tracking Engineered T Cell Therapies with an RNA-based Reporter Gene
    Chang, Bryan
    Shang, Catherine
    Lohith, Katheryn
    Farwell, Michael
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [30] UNIVERSAL CYTOTOXICITY ASSAY FOR POTENCY TESTING OF T CELL THERAPIES
    Lakshmipathy, U.
    MacArthur, C. C.
    Revankar, C.
    Coggan, A.
    [J]. CYTOTHERAPY, 2021, 23 (05) : S176 - S176